Combined hormonal contraceptives: realisation of the EU Commission's implementing decisions
2014.04.03
Active substance: combined hormonal contraceptives
In its notice of 31 March 2014, the Federal Institute for Drugs and Medical Devices has ruled the realisation of the corresponding implementing decisions of the EU Commission K(2014)307 of 16 January 2014.
To the risk assessment procedure (BfArM) (available in German only)
For details on the procedure please click on the following link to the homepage of the European Medicines Agency (EMA):